fibrosis treatment

AUSTIN, Texas, June 11, 2026 Rein Therapeutics, Inc. (NASDAQ: RNTX) announced the expansion of its ongoing Phase 2 RENEW...

Ingelheim, Germany – May 22, 2026 Boehringer Ingelheim announced that the European Medicines Agency’s Committee for Medicinal Products for...

SAN DIEGO, May 11, 2026 aTyr Pharma announced a major regulatory and clinical development update for its lead investigational...